Skip to search formSkip to main contentSkip to account menu

cisplatin/cytarabine/methylprednisolone/pixantrone/rituximab

Known as: ARA-C/BBR 2778/CDDP/MePRDL/MOAB IDEC-C2B8 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Purpose Berberine (BBR), a major ingredient extracted from Coptis chinensis, is a natural drug with limited oral bioavailability… 
2019
2019
Berberine (BBR) is an isoquinoline alkaloid, reported to have multiple pharmacological functions. However, its effects against… 
2018
2018
BackgroundRecently, we found that berberine (BBR) exerts anti-acute myeloid leukemia activity, particularly toward high-risk and… 
2018
2018
Introduction Berberine (BBR) is a plant-derived benzylisoquinoline alkaloid and has been demonstrated to be a potential treatment… 
2017
2017
Objective: To investigate the effect of berberine (BBR) on intestinal barrier function in nonalcoholic fat liver disease (NAFLD… 
Highly Cited
2013
Highly Cited
2013
The high aqueous solubility, poor permeability, and absorption of berberine (BBR) result in its low plasma level after oral… 
Highly Cited
2001
Highly Cited
2001
Background —Diagnosis of bundle-branch reentry ventricular tachycardia (BBR-VT) by the standard approach is challenging, and this…